| Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity Z Chen, Z Wang, JC Pang, Y Yu, S Bieerkehazhi, J Lu, T Hu, Y Zhao, X Xu, ... Scientific reports 6 (1), 29090, 2016 | 81 | 2016 |
| Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis Y Wang, L Wang, S Guan, W Cao, H Wang, Z Chen, Y Zhao, Y Yu, ... Scientific reports 6 (1), 19423, 2016 | 64 | 2016 |
| International consensus statement on allergy and rhinology: sinonasal tumors EC Kuan, EW Wang, ND Adappa, DM Beswick, NR London Jr, SY Su, ... International forum of allergy & rhinology 14 (2), 149-608, 2024 | 48 | 2024 |
| Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis Z Chen, L Wang, D Yao, T Yang, WM Cao, J Dou, JC Pang, S Guan, ... Scientific reports 6 (1), 38011, 2016 | 44 | 2016 |
| Acquisition of cisplatin resistance shifts head and neck squamous cell carcinoma metabolism toward neutralization of oxidative stress W Yu, Y Chen, N Putluri, C Coarfa, MJ Robertson, V Putluri, F Stossi, ... Cancers 12 (6), 1670, 2020 | 42 | 2020 |
| Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling S Bieerkehazhi, Z Chen, Y Zhao, Y Yu, H Zhang, SA Vasudevan, ... Oncotarget 8 (1), 1469, 2016 | 34 | 2016 |
| Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma X Mao, Z Chen, Y Zhao, Y Yu, S Guan, SE Woodfield, SA Vasudevan, ... Oncotarget 8 (1), 1555, 2016 | 28 | 2016 |
| Novel proteasome inhibitor ixazomib sensitizes neuroblastoma cells to doxorubicin treatment H Li, Z Chen, T Hu, L Wang, Y Yu, Y Zhao, W Sun, S Guan, JC Pang, ... Scientific reports 6 (1), 34397, 2016 | 27 | 2016 |
| A web-based deep learning model for automated diagnosis of otoscopic images K Tsutsumi, K Goshtasbi, A Risbud, P Khosravi, JC Pang, HW Lin, ... Otology & Neurotology 42 (9), e1382-e1388, 2021 | 20 | 2021 |
| Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo Z Chen, Y Zhao, Y Yu, JC Pang, SE Woodfield, L Tao, S Guan, H Zhang, ... Oncotarget 8 (61), 104090, 2017 | 18 | 2017 |
| Prognostic factors and outcomes of de novo sinonasal squamous cell carcinoma: A systematic review and meta-analysis ES Nguyen, A Risbud, JL Birkenbeuel, LS Murphy, K Goshtasbi, JC Pang, ... Otolaryngology–Head and Neck Surgery 166 (3), 434-443, 2022 | 17 | 2022 |
| Intranasal anticholinergics for treatment of chronic rhinitis: systematic review and meta‐analysis JC Pang, M Vasudev, AT Du, MM Nottoli, K Dang, EC Kuan The Laryngoscope 133 (4), 722-731, 2023 | 12 | 2023 |
| The global otolaryngology–head and neck surgery workforce B Petrucci, S Okerosi, RH Patterson, SB Hobday, V Salano, ... JAMA Otolaryngology–Head & Neck Surgery 149 (10), 904-911, 2023 | 11 | 2023 |
| The influence of facility volume and type on skull base chordoma treatment and outcomes AT Du, JC Pang, R Victor, LLT Meller, SJ Torabi, K Goshtasbi, MG Kim, ... World Neurosurgery 166, e561-e567, 2022 | 10 | 2022 |
| Characteristics and outcomes in pediatric versus adult craniopharyngiomas: A systematic review and meta-analysis JC Pang, DD Chung, J Wang, A Abiri, BV Lien, AS Himstead, ... Neurosurgery 92 (6), 1112-1129, 2023 | 9 | 2023 |
| Association between olfactory dysfunction and critical illness and mortality in COVID-19: a meta-analysis K Goshtasbi, J Pang, BM Lehrich, M Vasudev, JL Birkenbeuel, A Abiri, ... Otolaryngology–Head and Neck Surgery 166 (2), 388-392, 2022 | 9 | 2022 |
| Outcomes of perioperative vasopressor use for hemodynamic management of patients undergoing free flap surgery: A systematic review and meta‐analysis L Michelle, BF Bitner, JC Pang, MH Berger, YM Haidar, GR Rajan, T Tjoa Head & neck 45 (3), 721-732, 2023 | 8 | 2023 |
| Long‐term outcomes in sinonasal squamous cell carcinoma arising from inverted papilloma: Systematic review JL Birkenbeuel, JC Pang, A Lee, ES Nguyen, A Risbud, K Goshtasbi, ... Head & Neck 44 (4), 1014-1029, 2022 | 8 | 2022 |
| Prognostic utility of tumor stage versus american thyroid association risk class in thyroid cancer A Abiri, J Pang, KR Prasad, K Goshtasbi, EC Kuan, WB Armstrong, ... The Laryngoscope 133 (1), 205-211, 2023 | 4 | 2023 |
| Clinical and technical factors in endoscopic skull base surgery associated with reconstructive success. A Abiri, BF Bitner, TV Nguyen, JC Pang, KM Roman, M Vasudev, ... Rhinology, 2024 | 3 | 2024 |
Arash AbiriUniversity of California, Irvineuci.edu üzerinde doğrulanmış e-posta adresine sahip
